Tandem Diabetes Care Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Tandem Diabetes Care (TNDM) PT Raised to $28 at Cowen
July 31, 2018 6:25 AM EDTCowen raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $28.00 (from $25.00) while maintaining an Outperform rating following beat and raise.
Analyst Doug Schenkel commented, "TNDM posted a big revenue beat and guidance raise; we expect upside to continue through 2019/2020 and increased... More
Tandem Diabetes (TNDM) Misses Q2 EPS by 82c, Revenues Beat; Offers FY18 Revenue Outlook
July 30, 2018 4:16 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($1.17), $0.82 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $34.1 million versus the consensus estimate of $29.67 million.
Second Quarter 2018 Results
In comparing the second quarter of 2018 to the same period of 2017:
Pump shipments increased 59 percent to 5,447 pumps from 3,427 pumpsSales... More